Skip to content
Open access · CC-BY via OpenAlex

Strategies for in vivo reprogramming

Andreas Ofenbauer, Baris Tursun

Current Opinion in Cell Biology · 2019 · ▲ 25 citations

Abstract

Reprogramming has the potential to provide specific cell types for regenerative medicine applications aiming at replacing tissues that have been lost or damaged due to degenerative diseases and injury. In this review we discuss the latest strategies and advances of in vivo reprogramming to convert cell identities in living organisms, including reprogramming induced by transcription factors (TFs) and CRISPR/dCas9 synthetic TFs, as well as by cell fusion and small molecules. We also provide a brief recap of reprogramming barriers, the effect of senescence(definition) on reprogramming efficiency, and strategies to deliver reprogramming factors in vivo. Because of the limited space, we omit dwelling on naturally occurring reprogramming phenomena such as developmentally programmed transdifferentiation found in the nematode Caenorhabditis elegans.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1016/j.ceb.2019.06.002
Canonical
link ↗
Fetched
2026-08-03 MST

Cite this

APA
Ofenbauer, A., &amp; Tursun, B. (2019). Strategies for in vivo reprogramming. <em>Current Opinion in Cell Biology</em>. https://doi.org/10.1016/j.ceb.2019.06.002
Vancouver
Ofenbauer A, Tursun B. Strategies for in vivo reprogramming. Current Opinion in Cell Biology. 2019. doi:10.1016/j.ceb.2019.06.002.
BibTeX
@article{andreas2019Strate, title = {Strategies for in vivo reprogramming}, author = {Andreas Ofenbauer and Baris Tursun}, journal = {Current Opinion in Cell Biology}, year = {2019}, doi = {10.1016/j.ceb.2019.06.002}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings